Medical Daily: Deadly Brain Cancer Glioblastoma Multiforme Could Soon Be Treatable

Upon diagnosis, individuals with gliobastoma multiforme usually don’t live longer than about 15 months.

Scientists at the Salk Institute have found a key driver for treatment of this deadly brain cancer by discovering how these tumor cells multiply and how to turn off tumor growth by using a peptide called NBD. With support from the Trust’s Basic Medical Research Program, Salk scientists are working towards improved treatment outcomes for the disease by studying how glioblastoma multiforme spreads. The study’s complete findings were recently reported in the journal Science Advances.